Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Fatty acid-binding protein, intestinal (Fatty acid-binding protein 2) (Intestinal-type fatty acid-binding protein) (I-FABP)

 FABPI_HUMAN             Reviewed;         132 AA.
P12104; Q2NKJ1;
01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
23-JAN-2007, sequence version 2.
20-JUN-2018, entry version 164.
RecName: Full=Fatty acid-binding protein, intestinal;
AltName: Full=Fatty acid-binding protein 2;
AltName: Full=Intestinal-type fatty acid-binding protein;
Short=I-FABP;
Name=FABP2; Synonyms=FABPI;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=2824476;
Sweetser D.A., Birkenmeier E.H., Klisak I.J., Zollman S.,
Sparkes R.S., Mohandas T., Lusis A.J., Gordon J.I.;
"The human and rodent intestinal fatty acid binding protein genes. A
comparative analysis of their structure, expression, and linkage
relationships.";
J. Biol. Chem. 262:16060-16071(1987).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15815621; DOI=10.1038/nature03466;
Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
Waterston R.H., Wilson R.K.;
"Generation and annotation of the DNA sequences of human chromosomes 2
and 4.";
Nature 434:724-731(2005).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-55.
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[4]
TISSUE SPECIFICITY.
PubMed=14563446; DOI=10.1016/S0009-9120(03)00096-1;
Pelsers M.M.A.L., Namiot Z., Kisielewski W., Namiot A.,
Januszkiewicz M., Hermens W.T., Glatz J.F.C.;
"Intestinal-type and liver-type fatty acid-binding protein in the
intestine. Tissue distribution and clinical utility.";
Clin. Biochem. 36:529-535(2003).
[5]
INDUCTION BY EGF.
PubMed=10070036;
Darimont C., Gradoux N., de Pover A.;
"Epidermal growth factor regulates fatty acid uptake and metabolism in
Caco-2 cells.";
Am. J. Physiol. 276:G606-G612(1999).
[6]
MUTAGENESIS OF LEU-39; GLU-64; LEU-65; VAL-67; LEU-90 AND VAL-123.
PubMed=14567680; DOI=10.1021/bi0301688;
Rajabzadeh M., Kao J., Frieden C.;
"Consequences of single-site mutations in the intestinal fatty acid
binding protein.";
Biochemistry 42:12192-12199(2003).
[7]
STRUCTURE BY NMR.
TISSUE=Intestine;
PubMed=9204553; DOI=10.1023/A:1018666522787;
Zhang F., Luecke C., Baier L.J., Sacchettini J.C., Hamilton J.A.;
"Solution structure of human intestinal fatty acid binding protein:
implications for ligand entry and exit.";
J. Biomol. NMR 9:213-228(1997).
[8]
STRUCTURE BY NMR OF VARIANT THR-55.
PubMed=12809489; DOI=10.1021/bi0273617;
Zhang F., Luecke C., Baier L.J., Sacchettini J.C., Hamilton J.A.;
"Solution structure of human intestinal fatty acid binding protein
with a naturally-occurring single amino acid substitution (A54T) that
is associated with altered lipid metabolism.";
Biochemistry 42:7339-7347(2003).
[9]
VARIANT THR-55.
PubMed=7883976; DOI=10.1172/JCI117778;
Baier L.J., Sacchettini J.C., Knowler W.C., Eads J., Paolisso G.,
Tataranni P.A., Mochizuki H., Bennett P.H., Bogardus C., Prochazka M.;
"An amino acid substitution in the human intestinal fatty acid binding
protein is associated with increased fatty acid binding, increased fat
oxidation, and insulin resistance.";
J. Clin. Invest. 95:1281-1287(1995).
[10]
VARIANT THR-55.
PubMed=12899384;
Kunsan X., Taisan Z., Weiping J., Duoqi S., Wei D., Jie L., Junxi L.,
Rong Z.;
"The association of Ala54Thr variant of intestinal fatty acid binding
protein gene with general and regional adipose tissue depots.";
Chin. Med. Sci. J. 14:46-51(1999).
-!- FUNCTION: FABP are thought to play a role in the intracellular
transport of long-chain fatty acids and their acyl-CoA esters.
FABP2 is probably involved in triglyceride-rich lipoprotein
synthesis. Binds saturated long-chain fatty acids with a high
affinity, but binds with a lower affinity to unsaturated long-
chain fatty acids. FABP2 may also help maintain energy homeostasis
by functioning as a lipid sensor.
-!- INTERACTION:
O95994:AGR2; NbExp=6; IntAct=EBI-3905109, EBI-712648;
Q9NYB0:TERF2IP; NbExp=2; IntAct=EBI-3905109, EBI-750109;
-!- SUBCELLULAR LOCATION: Cytoplasm.
-!- TISSUE SPECIFICITY: Expressed in the small intestine and at much
lower levels in the large intestine. Highest expression levels in
the jejunum. {ECO:0000269|PubMed:14563446}.
-!- INDUCTION: By EGF. {ECO:0000269|PubMed:10070036}.
-!- DOMAIN: Forms a beta-barrel structure that accommodates the
hydrophobic ligand in its interior.
-!- SIMILARITY: Belongs to the calycin superfamily. Fatty-acid binding
protein (FABP) family. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; M18079; AAA52417.1; -; Genomic_DNA.
EMBL; AC092656; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BC069466; AAH69466.1; -; mRNA.
EMBL; BC069617; AAH69617.1; -; mRNA.
EMBL; BC069625; AAH69625.1; -; mRNA.
EMBL; BC069637; AAH69637.1; -; mRNA.
EMBL; BC111791; AAI11792.1; -; mRNA.
CCDS; CCDS3712.1; -.
PIR; A29781; FZHUI.
RefSeq; NP_000125.2; NM_000134.3.
UniGene; Hs.282265; -.
PDB; 1KZW; NMR; -; A=2-132.
PDB; 1KZX; NMR; -; A=2-132.
PDB; 2MJI; NMR; -; A=2-132.
PDB; 2MO5; NMR; -; A=2-132.
PDB; 3AKM; X-ray; 1.90 A; A/B/C/D=2-132.
PDB; 3IFB; NMR; -; A=2-132.
PDBsum; 1KZW; -.
PDBsum; 1KZX; -.
PDBsum; 2MJI; -.
PDBsum; 2MO5; -.
PDBsum; 3AKM; -.
PDBsum; 3IFB; -.
ProteinModelPortal; P12104; -.
SMR; P12104; -.
BioGrid; 108467; 3.
IntAct; P12104; 3.
STRING; 9606.ENSP00000274024; -.
BindingDB; P12104; -.
ChEMBL; CHEMBL4879; -.
DrugBank; DB04557; Arachidonic Acid.
DrugBank; DB00783; Estradiol.
DrugBank; DB01050; Ibuprofen.
DrugBank; DB08231; MYRISTIC ACID.
DrugBank; DB03796; Palmitic Acid.
DrugBank; DB01138; Sulfinpyrazone.
SwissLipids; SLP:000001520; -.
iPTMnet; P12104; -.
PhosphoSitePlus; P12104; -.
BioMuta; FABP2; -.
DMDM; 119805; -.
PaxDb; P12104; -.
PeptideAtlas; P12104; -.
PRIDE; P12104; -.
ProteomicsDB; 52825; -.
DNASU; 2169; -.
Ensembl; ENST00000274024; ENSP00000274024; ENSG00000145384.
GeneID; 2169; -.
KEGG; hsa:2169; -.
UCSC; uc003icw.4; human.
CTD; 2169; -.
DisGeNET; 2169; -.
EuPathDB; HostDB:ENSG00000145384.3; -.
GeneCards; FABP2; -.
H-InvDB; HIX0004469; -.
HGNC; HGNC:3556; FABP2.
HPA; CAB047325; -.
HPA; CAB047326; -.
HPA; HPA034607; -.
MIM; 134640; gene.
neXtProt; NX_P12104; -.
PharmGKB; PA27957; -.
eggNOG; KOG4015; Eukaryota.
eggNOG; ENOG4111US8; LUCA.
HOGENOM; HOG000004829; -.
HOVERGEN; HBG005633; -.
InParanoid; P12104; -.
KO; K08751; -.
OrthoDB; EOG091G0QSV; -.
PhylomeDB; P12104; -.
TreeFam; TF316894; -.
Reactome; R-HSA-163560; Triglyceride catabolism.
ChiTaRS; FABP2; human.
EvolutionaryTrace; P12104; -.
GeneWiki; FABP2; -.
GenomeRNAi; 2169; -.
PRO; PR:P12104; -.
Proteomes; UP000005640; Chromosome 4.
Bgee; ENSG00000145384; -.
CleanEx; HS_FABP2; -.
Genevisible; P12104; HS.
GO; GO:0005829; C:cytosol; TAS:Reactome.
GO; GO:0005504; F:fatty acid binding; TAS:ProtInc.
GO; GO:0036041; F:long-chain fatty acid binding; IDA:GO_Central.
GO; GO:0098856; P:intestinal lipid absorption; IMP:GO_Central.
GO; GO:0019433; P:triglyceride catabolic process; TAS:Reactome.
Gene3D; 2.40.128.20; -; 1.
InterPro; IPR012674; Calycin.
InterPro; IPR031272; FABP2.
InterPro; IPR000463; Fatty_acid-bd.
InterPro; IPR031259; ILBP.
InterPro; IPR000566; Lipocln_cytosolic_FA-bd_dom.
PANTHER; PTHR11955; PTHR11955; 1.
PANTHER; PTHR11955:SF89; PTHR11955:SF89; 1.
Pfam; PF00061; Lipocalin; 1.
PRINTS; PR00178; FATTYACIDBP.
SUPFAM; SSF50814; SSF50814; 1.
PROSITE; PS00214; FABP; 1.
1: Evidence at protein level;
3D-structure; Acetylation; Complete proteome; Cytoplasm;
Lipid-binding; Polymorphism; Reference proteome; Transport.
INIT_MET 1 1 Removed. {ECO:0000250|UniProtKB:P02693}.
CHAIN 2 132 Fatty acid-binding protein, intestinal.
/FTId=PRO_0000067328.
BINDING 83 83 Fatty acid. {ECO:0000250}.
BINDING 107 107 Fatty acid. {ECO:0000250}.
MOD_RES 2 2 N-acetylalanine.
{ECO:0000250|UniProtKB:P02693}.
VARIANT 55 55 A -> T (found in 29% of the population;
associated with increased plasma insulin
concentration, increased fat oxidation
and insulin resistance; 2-fold greater
affinity for long-chain fatty acids;
dbSNP:rs1799883).
{ECO:0000269|PubMed:12809489,
ECO:0000269|PubMed:12899384,
ECO:0000269|PubMed:15489334,
ECO:0000269|PubMed:7883976}.
/FTId=VAR_002379.
MUTAGEN 39 39 L->G: Reduced stability.
{ECO:0000269|PubMed:14567680}.
MUTAGEN 64 64 E->G: Localized reduction in stability.
{ECO:0000269|PubMed:14567680}.
MUTAGEN 65 65 L->A: Reduced stability.
{ECO:0000269|PubMed:14567680}.
MUTAGEN 65 65 L->G: Reduced stability.
{ECO:0000269|PubMed:14567680}.
MUTAGEN 67 67 V->G: Localized reduction in stability.
{ECO:0000269|PubMed:14567680}.
MUTAGEN 90 90 L->G: Reduced stability.
{ECO:0000269|PubMed:14567680}.
MUTAGEN 123 123 V->G: Reduced stability.
{ECO:0000269|PubMed:14567680}.
STRAND 5 14 {ECO:0000244|PDB:3AKM}.
HELIX 15 22 {ECO:0000244|PDB:3AKM}.
HELIX 26 32 {ECO:0000244|PDB:3AKM}.
TURN 33 35 {ECO:0000244|PDB:3IFB}.
STRAND 38 44 {ECO:0000244|PDB:3AKM}.
STRAND 47 53 {ECO:0000244|PDB:3AKM}.
STRAND 58 64 {ECO:0000244|PDB:3AKM}.
STRAND 69 72 {ECO:0000244|PDB:3AKM}.
STRAND 74 76 {ECO:0000244|PDB:1KZW}.
STRAND 78 86 {ECO:0000244|PDB:3AKM}.
STRAND 89 96 {ECO:0000244|PDB:3AKM}.
TURN 97 99 {ECO:0000244|PDB:3AKM}.
STRAND 102 110 {ECO:0000244|PDB:3AKM}.
STRAND 113 120 {ECO:0000244|PDB:3AKM}.
STRAND 123 131 {ECO:0000244|PDB:3AKM}.
SEQUENCE 132 AA; 15207 MW; 68330E3D81792CAF CRC64;
MAFDSTWKVD RSENYDKFME KMGVNIVKRK LAAHDNLKLT ITQEGNKFTV KESSAFRNIE
VVFELGVTFN YNLADGTELR GTWSLEGNKL IGKFKRTDNG NELNTVREII GDELVQTYVY
EGVEAKRIFK KD


Related products :

Catalog number Product name Quantity
E0559h ELISA kit FABP2,FABPI,Fatty acid-binding protein 2,Fatty acid-binding protein, intestinal,Homo sapiens,Human,I-FABP,Intestinal-type fatty acid-binding protein 96T
U0559h CLIA FABP2,FABPI,Fatty acid-binding protein 2,Fatty acid-binding protein, intestinal,Homo sapiens,Human,I-FABP,Intestinal-type fatty acid-binding protein 96T
E0559h ELISA FABP2,FABPI,Fatty acid-binding protein 2,Fatty acid-binding protein, intestinal,Homo sapiens,Human,I-FABP,Intestinal-type fatty acid-binding protein 96T
U0559m CLIA Fabp2,Fabpi,Fatty acid-binding protein 2,Fatty acid-binding protein, intestinal,I-FABP,Intestinal-type fatty acid-binding protein,Mouse,Mus musculus 96T
E0559m ELISA kit Fabp2,Fabpi,Fatty acid-binding protein 2,Fatty acid-binding protein, intestinal,I-FABP,Intestinal-type fatty acid-binding protein,Mouse,Mus musculus 96T
U0559b CLIA Bos taurus,Bovine,FABP2,FABPI,Fatty acid-binding protein 2,Fatty acid-binding protein, intestinal,I-FABP,Intestinal-type fatty acid-binding protein 96T
E0559b ELISA kit Bos taurus,Bovine,FABP2,FABPI,Fatty acid-binding protein 2,Fatty acid-binding protein, intestinal,I-FABP,Intestinal-type fatty acid-binding protein 96T
E0559r ELISA kit Fabp2,Fabpi,Fatty acid-binding protein 2,Fatty acid-binding protein, intestinal,I-FABP,Intestinal-type fatty acid-binding protein,Rat,Rattus norvegicus 96T
U0559r CLIA Fabp2,Fabpi,Fatty acid-binding protein 2,Fatty acid-binding protein, intestinal,I-FABP,Intestinal-type fatty acid-binding protein,Rat,Rattus norvegicus 96T
E0559b ELISA Bos taurus,Bovine,FABP2,FABPI,Fatty acid-binding protein 2,Fatty acid-binding protein, intestinal,I-FABP,Intestinal-type fatty acid-binding protein 96T
E0559r ELISA Fabp2,Fabpi,Fatty acid-binding protein 2,Fatty acid-binding protein, intestinal,I-FABP,Intestinal-type fatty acid-binding protein,Rat,Rattus norvegicus 96T
E0559m ELISA Fabp2,Fabpi,Fatty acid-binding protein 2,Fatty acid-binding protein, intestinal,I-FABP,Intestinal-type fatty acid-binding protein,Mouse,Mus musculus 96T
E0559p ELISA kit FABP2,FABPI,Fatty acid-binding protein 2,Fatty acid-binding protein, intestinal,I-FABP,Intestinal-type fatty acid-binding protein,Pig,Sus scrofa 96T
U0559p CLIA FABP2,FABPI,Fatty acid-binding protein 2,Fatty acid-binding protein, intestinal,I-FABP,Intestinal-type fatty acid-binding protein,Pig,Sus scrofa 96T
E0559p ELISA FABP2,FABPI,Fatty acid-binding protein 2,Fatty acid-binding protein, intestinal,I-FABP,Intestinal-type fatty acid-binding protein,Pig,Sus scrofa 96T
E0344h ELISA E-FABP,Epidermal-type fatty acid-binding protein,FABP5,Fatty acid-binding protein 5,Fatty acid-binding protein, epidermal,Homo sapiens,Human,PA-FABP,Psoriasis-associated fatty acid-binding prote 96T
U0344h CLIA E-FABP,Epidermal-type fatty acid-binding protein,FABP5,Fatty acid-binding protein 5,Fatty acid-binding protein, epidermal,Homo sapiens,Human,PA-FABP,Psoriasis-associated fatty acid-binding protei 96T
E0344r ELISA C-FABP,Cutaneous fatty acid-binding protein,DA11,E-FABP,Epidermal-type fatty acid-binding protein,Fabp5,Fatty acid-binding protein 5,Fatty acid-binding protein, epidermal,Rat,Rattus norvegicus 96T
E0344r ELISA kit C-FABP,Cutaneous fatty acid-binding protein,DA11,E-FABP,Epidermal-type fatty acid-binding protein,Fabp5,Fatty acid-binding protein 5,Fatty acid-binding protein, epidermal,Rat,Rattus norvegi 96T
U0344r CLIA C-FABP,Cutaneous fatty acid-binding protein,DA11,E-FABP,Epidermal-type fatty acid-binding protein,Fabp5,Fatty acid-binding protein 5,Fatty acid-binding protein, epidermal,Rat,Rattus norvegicus 96T
E0344h ELISA kit E-FABP,Epidermal-type fatty acid-binding protein,FABP5,Fatty acid-binding protein 5,Fatty acid-binding protein, epidermal,Homo sapiens,Human,PA-FABP,Psoriasis-associated fatty acid-binding 96T
E0344b ELISA kit Bos taurus,Bovine,Differentiation-associated lipid-binding protein LP2,E-FABP,Epidermal-type fatty acid-binding protein,FABP5,Fatty acid-binding protein 5,Fatty acid-binding protein, epider 96T
10-663-45624 Fatty Acid Binding Protein (FABP) Human - H-FABP; Heart-type fatty acid-binding protein; Muscle fatty acid-binding protein; M-FABP; Mammary-derived growth inhibitor; MDGI N_A 0.02 mg
10-663-45624 Fatty Acid Binding Protein (FABP) Human - H-FABP; Heart-type fatty acid-binding protein; Muscle fatty acid-binding protein; M-FABP; Mammary-derived growth inhibitor; MDGI N_A 0.005 mg
10-663-45624 Fatty Acid Binding Protein (FABP) Human - H-FABP; Heart-type fatty acid-binding protein; Muscle fatty acid-binding protein; M-FABP; Mammary-derived growth inhibitor; MDGI N_A 1 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur